Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Other cell-surface proteins with accessible lysine residues" refers to a broad category of membrane-associated proteins that possess lysine side chains (epsilon-amino groups) exposed to the extracellular environment (Hermanson, G. T., Bioconjugate Techniques, 2013 [1]). These primary amines are highly nucleophilic and serve as the primary chemical handles for the covalent attachment of drugs, linkers, and imaging probes through electrophilic substitution or addition reactions (Agarwal & Bertozzi, Bioconjugate Chemistry, 2015 [2]). In a therapeutic context, this is not a single biological target but rather a chemical site of action for non-specific cross-linking agents or the methodology used to generate first-generation antibody-drug conjugates (ADCs) (ChEMBL Database [3]). Because lysine is one of the most abundant amino acids on protein surfaces, targeting these residues typically results in a heterogeneous mixture of modified proteins, which can complicate the pharmacokinetic and safety profiles of the resulting therapeutic (Nature Reviews Drug Discovery, 2022 [4]). Consequently, while essential for many bioconjugation strategies, this 'target' lacks the specificity required for traditional receptor-mediated drug design.
Covalent modification of the epsilon-amino group of lysine residues through nucleophilic attack on electrophilic reagents, such as aldehydes or NHS esters, to form stable conjugates.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other cell-surface proteins with accessible lysine residues.